임세진 (성균관대학교 의과대학)님 | 한빛사연구자 > 한빛사

성균관대학교 의과대학

CV File

최종업데이트 2024.09.02.

Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends
- Exp. Mol. Med., 02 September 2024 | https://doi.org/10.1038/s12276-024-01301-3
- 2024-09
- 생명과학
- 한빛사논문
Two distinct subpopulations of marginal zone B cells exhibit differential antibody-producing capacities and radioresistance
- Cell. Mol. Immunol., Mar 01 2024, | https://doi.org/10.1038/s41423-024-01126-0
- 2024-03
- 의약학
- 한빛사논문
- 임세진(성균관대 의과대학, Emory University School of Medicine)
Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer.
- Proc. Natl. Acad. Sci. USA, Oct 10 2023, 120 (41) | https://doi.org/10.1073/pnas.2221985120
- 2023-10
- 생명과학
- 한빛사논문
Defining a TCF1-expressing progenitor allogeneic CD8+ T cell subset in acute graft-versus-host disease.
- Nat. Commun., Sep 22 2023, 14 (1) 5869 | https://doi.org/10.1038/s41467-023-41357-9
- 2023-09
- 생명과학
- 한빛사논문
- 임세진(성균관대학교 의과대학, Emory University School of Medicine)
  Interview
PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection
- Proc. Natl. Acad. Sci. USA, First published February 7, 2020 | https://doi.org/10.1073/pnas.1917298117
- 2020-02
- 한빛사논문
- 임세진(Emory University School of Medicine)
Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade
- Proc. Natl. Acad. Sci. USA, July 9, 2019, 116 (28) 14113-14118 | https://doi.org/10.1073/pnas.1903520116
- 2019-07
- 한빛사논문
- 임세진(Emory University School of Medicine)
  Interview
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- Nature, 537, 417-421 (15 September 2016) | doi:10.1038/nature19330
- 2016-09
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기